REPORT ID 2882

Global Gastrointestinal Therapeutics Market Research Report 2017

Publish Date
12-Dec-17
Pages
129
Format
Electronic (PDF)

In this report, the global Gastrointestinal Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Gastrointestinal Therapeutics in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Gastrointestinal Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Johnson & Johnson
    AbbVie
    Allergan
    Takeda
    Novartis
    Pfizer
    GlaxoSmithKline
    Merck
    UCB (Belgium)
    F. Hoffmann-La Roche
    Eli Lilly
    AstraZeneca
    Procter & Gamble
    Eisai
    Shire Pharmaceuticals
    Ferring Pharmaceuticals
    Kyowa Hakko Kirin
    Salix Pharmaceuticals
    Ono Pharmaceutical
    TSD Japan
    RedHill Biopharma
    Kaken Pharmaceutical
    Amgen
    Synergy Pharmaceuticals
    Ajinomoto
    Kissei Pharmaceutical
    Hutchison Medi Pharma
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Tablets
    Injection
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    IBD
    Irritable Bowel Syndrome (IBS)
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Gastrointestinal Therapeutics Market Research Report 2017
1 Gastrointestinal Therapeutics Market Overview
    1.1 Product Overview and Scope of Gastrointestinal Therapeutics
    1.2 Gastrointestinal Therapeutics Segment by Type (Product Category)
        1.2.1 Global Gastrointestinal Therapeutics Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Gastrointestinal Therapeutics Production Market Share by Type (Product Category) in 2016
        1.2.3 Tablets
        1.2.4 Injection
    1.3 Global Gastrointestinal Therapeutics Segment by Application
        1.3.1 Gastrointestinal Therapeutics Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 IBD
        1.3.3 Irritable Bowel Syndrome (IBS)
        1.3.4 Other
    1.4 Global Gastrointestinal Therapeutics Market by Region (2012-2022)
        1.4.1 Global Gastrointestinal Therapeutics Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Gastrointestinal Therapeutics (2012-2022)
        1.5.1 Global Gastrointestinal Therapeutics Revenue Status and Outlook (2012-2022)
        1.5.2 Global Gastrointestinal Therapeutics Capacity, Production Status and Outlook (2012-2022)

2 Global Gastrointestinal Therapeutics Market Competition by Manufacturers
    2.1 Global Gastrointestinal Therapeutics Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Gastrointestinal Therapeutics Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Gastrointestinal Therapeutics Production and Share by Manufacturers (2012-2017)
    2.2 Global Gastrointestinal Therapeutics Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Gastrointestinal Therapeutics Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Gastrointestinal Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Gastrointestinal Therapeutics Market Competitive Situation and Trends
        2.5.1 Gastrointestinal Therapeutics Market Concentration Rate
        2.5.2 Gastrointestinal Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Gastrointestinal Therapeutics Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Gastrointestinal Therapeutics Capacity and Market Share by Region (2012-2017)
    3.2 Global Gastrointestinal Therapeutics Production and Market Share by Region (2012-2017)
    3.3 Global Gastrointestinal Therapeutics Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Gastrointestinal Therapeutics Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Gastrointestinal Therapeutics Consumption by Region (2012-2017)
    4.2 North America Gastrointestinal Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Gastrointestinal Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.4 China Gastrointestinal Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Gastrointestinal Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Gastrointestinal Therapeutics Production, Consumption, Export, Import (2012-2017)
    4.7 India Gastrointestinal Therapeutics Production, Consumption, Export, Import (2012-2017)

5 Global Gastrointestinal Therapeutics Production, Revenue (Value), Price Trend by Type
    5.1 Global Gastrointestinal Therapeutics Production and Market Share by Type (2012-2017)
    5.2 Global Gastrointestinal Therapeutics Revenue and Market Share by Type (2012-2017)
    5.3 Global Gastrointestinal Therapeutics Price by Type (2012-2017)
    5.4 Global Gastrointestinal Therapeutics Production Growth by Type (2012-2017)

6 Global Gastrointestinal Therapeutics Market Analysis by Application
    6.1 Global Gastrointestinal Therapeutics Consumption and Market Share by Application (2012-2017)
    6.2 Global Gastrointestinal Therapeutics Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Gastrointestinal Therapeutics Manufacturers Profiles/Analysis
    7.1 Johnson & Johnson
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Johnson & Johnson Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 AbbVie
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 AbbVie Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Allergan
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Allergan Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Takeda
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Takeda Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Novartis
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Novartis Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Pfizer
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Pfizer Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 GlaxoSmithKline
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 GlaxoSmithKline Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Merck
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Merck Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 UCB (Belgium)
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 UCB (Belgium) Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 F. Hoffmann-La Roche
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Gastrointestinal Therapeutics Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Eli Lilly
    7.12 AstraZeneca
    7.13 Procter & Gamble
    7.14 Eisai
    7.15 Shire Pharmaceuticals
    7.16 Ferring Pharmaceuticals
    7.17 Kyowa Hakko Kirin
    7.18 Salix Pharmaceuticals
    7.19 Ono Pharmaceutical
    7.20 TSD Japan
    7.21 RedHill Biopharma
    7.22 Kaken Pharmaceutical
    7.23 Amgen
    7.24 Synergy Pharmaceuticals
    7.25 Ajinomoto
    7.26 Kissei Pharmaceutical
    7.27 Hutchison Medi Pharma

8 Gastrointestinal Therapeutics Manufacturing Cost Analysis
    8.1 Gastrointestinal Therapeutics Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Gastrointestinal Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Gastrointestinal Therapeutics Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Gastrointestinal Therapeutics Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Gastrointestinal Therapeutics Market Forecast (2017-2022)
    12.1 Global Gastrointestinal Therapeutics Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Gastrointestinal Therapeutics Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Gastrointestinal Therapeutics Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Gastrointestinal Therapeutics Price and Trend Forecast (2017-2022)
    12.2 Global Gastrointestinal Therapeutics Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Gastrointestinal Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Gastrointestinal Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Gastrointestinal Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Gastrointestinal Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Gastrointestinal Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Gastrointestinal Therapeutics Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Gastrointestinal Therapeutics Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Gastrointestinal Therapeutics Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer